Literature DB >> 7380115

Immunologic features of mice with streptozotocin-induced diabetes: depression of their immune responses to sheep red blood cells.

T Ishibashi, Y Kitahara, Y Harada, S Harada, M Takamoto, T Ishibashi.   

Abstract

The immune responsiveness in streptozotocin (SZ)-induced diabetic mice was studied using the immune responses to sheep red blood cells (SRBC) as an indicator system. In SZ-diabetic mice, the weights of such lymphoid organs as the thymus and spleen were significantly decreased with time after SZ administration, whereas the weight of liver was markedly increased. In SZ-diabetic mice, the level of delayed type hypersensitivity (DTH) to SRBC was not lower than that in normal controls in most cases, although the level of DTH was significantly depressed, on occasion, in SZ-diabetic mice. In contrast, antibody-forming activity, measured as the number of plaque-forming cells (PFC), was markedly decreased in SZ-diabetic mice. It seems that antibody production is more profoundly depressed than is DTH in SZ-diabetic mice. The transfer of normal thymus and bone marrow cells into SZ-diabetic mice caused only a partial restoration of PFC activity. When normal spleen cells were transferred into diabetic irradiated mice, proliferation of spleen cells and production of splenic PFC was greatly reduced as compared with normal irradiated mice. Treatment with insulin completely reversed such depression in the transfer system. These findings suggest that the chronic insulin-deficient diabetic state caused a depression and delay in the proliferation and differentiation of lymphoid cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7380115     DOI: 10.2337/diab.29.7.516

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

1.  Low dose streptozotocin causes stimulation of the immune system and of anti-islet cytotoxicity in mice.

Authors:  G Kantwerk-Funke; V Burkart; H Kolb
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

2.  Differential Impact of Chronic Hyperglycemia on Humoral Versus Cellular Primary Alloimmunity.

Authors:  Nicholas H Bishop; Michelle K Nelsen; K Scott Beard; Marilyne Coulombe; Ronald G Gill
Journal:  Diabetes       Date:  2017-01-09       Impact factor: 9.461

Review 3.  Multiple immunological abnormalities in patients with type 1 (insulin-dependent) diabetes mellitus.

Authors:  D W Drell; A L Notkins
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

4.  Alterations in immunological reactivity in encephalomyocarditis virus-induced murine diabetes. I. Defective primary IgM plaque forming cell responses to sheep erythrocytes: correction by islet cell transplantation.

Authors:  B S Handwerger; G Fernandes; T Riehm; J W Yoon; D E Sutherland; D M Brown
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

5.  Repopulation of the atrophied thymus in diabetic rats by insulin-like growth factor I.

Authors:  K Binz; P Joller; P Froesch; H Binz; J Zapf; E R Froesch
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

6.  Streptozotocin effects on T lymphocytes and bone marrow cells.

Authors:  W K Nichols; L L Vann; J B Spellman
Journal:  Clin Exp Immunol       Date:  1981-12       Impact factor: 4.330

7.  Reduced resistance to Pseudomonas septicaemia in diabetic mice.

Authors:  Y Kitahara; T Ishibashi; Y Harada; M Takamoto; K Tanaka
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

8.  Streptozotocin-associated lymphopenia in cynomolgus monkeys.

Authors:  Santosh Nagaraju; Suzanne Bertera; Amber Funair; Martin Wijkstrom; Massimo Trucco; David K C Cooper; Rita Bottino
Journal:  Islets       Date:  2014       Impact factor: 2.694

9.  Endangered Lymphocytes: The Effects of Alloxan and Streptozotocin on Immune Cells in Type 1 Induced Diabetes.

Authors:  Luiz A D Queiroz; Josiane B Assis; João P T Guimarães; Emanuella S A Sousa; Anália C Milhomem; Karen K S Sunahara; Anderson Sá-Nunes; Joilson O Martins
Journal:  Mediators Inflamm       Date:  2021-10-19       Impact factor: 4.711

Review 10.  Role of Caveolin-1 in Diabetes and Its Complications.

Authors:  Dania Haddad; Ashraf Al Madhoun; Rasheeba Nizam; Fahd Al-Mulla
Journal:  Oxid Med Cell Longev       Date:  2020-01-27       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.